Aurora Capital - Overview
Aurora Capital
Aurora Capital LLC (www.auroracapital.com) is a boutique investment bank and securities firm founded in 1994. We specialize in the life science sector, including biotechnology, biopharmaceuticals, pharmaceuticals, medical devices, medical diagnostics, medical instrumentation, medical technology, and occasionally, agricultural biotechnology, industrial biotechnology, and environmental biotechnology. Our team of experienced professionals engages in a rigorous process to select investment ideas and banking clients. We also have a network of qualified scientific, medical, and other advisors to support our work.
Our objective at Aurora Capital is to achieve equitable valuations for our investment banking clients while providing investor returns that align with the risks associated with emerging technologies. We have a division called LifeTech Capital that offers sell-side research to all (www.lifetechcapital.com) and provides investment banking and advisory services primarily focused on public reporting life science companies that are often undiscovered or underdiscovered by other investment banks.
On the securities and brokerage side of our business, we have knowledgeable and experienced registered representatives who possess a deep understanding and broad capabilities to meet our customers’ investing needs. They also have unique access to the securities offerings of our investment banking department, the resources of our clearing firm, and a comprehensive understanding of the life science sector.
In addition, our Hedge Fund/Direct Participation Program Group raises capital for hedge funds, funds of funds, and direct participation programs. We offer these unique investment opportunities exclusively to select groups of highly qualified institutions, individuals, and related entities.
Aurora Capital is headquartered in New York City and has offices in Boca Raton, FL, Chestnut Ridge and Greenvale, NY, and San Francisco, CA. We are dedicated to serving life science companies and their investors, as well as fulfilling our customers’ general investing needs. Our focus is to provide valuable or undiscovered investment opportunities to our clients and deliver high-quality service to a corporate finance client base that may be overlooked or underserved by major and regional investment banking organizations, primarily due to company or transaction size.